Insight Molecular Diagnostics (IMDX) Goodwill & Intangibles (2015 - 2025)

Insight Molecular Diagnostics has disclosed Goodwill & Intangibles across 10 years of filings, most recently posting $15.0 million for Q3 2025.

• Goodwill & Intangibles for Q3 2025 came in at $15.0 million, up 3318.18% year-over-year; the trailing twelve-month figure through Sep 2025 was $15.0 million (up 3318.18% YoY), and the FY2024 annual result was $15.0 million, down 73.59% from the prior year.
• Goodwill & Intangibles came in at $15.0 million for Q3 2025 at Insight Molecular Diagnostics, up from $14.6 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $113.4 million in Q1 2022 to a low of $440000.0 in Q2 2024.
• The 5-year median for Goodwill & Intangibles is $56.9 million (2023), against an average of $51.2 million.
• Across the five-year window, Goodwill & Intangibles tumbled 99.33% in 2024 and surged 3318.18% in 2025, its largest moves.
• Insight Molecular Diagnostics' Goodwill & Intangibles stood at $80.4 million in 2021, then retreated by 11.9% to $70.8 million in 2022, then slipped by 19.61% to $56.9 million in 2023, then plunged by 73.59% to $15.0 million in 2024, then changed by 0.0% to $15.0 million in 2025.
• The last three Goodwill & Intangibles figures came in at $15.0 million (Q3 2025), $14.6 million (Q2 2025), and $440000.0 (Q1 2025), per Business Quant data.